Drug resistance observed with many anti-infectives clearly highlights the need for new broad-spectrum agents to treat especially neglected tropical diseases (NTDs)caused by eukaryotic parasitic pathogens, including fungal infections. Herein, we show that the simple modification of one of the most well-known antifungal drugs, fluconazole, with organometallic moieties not only improves the activity of the parent drug but also broadens the scope of application of the new derivatives. These compounds were highly effective in vivo against pathogenic fungal infections and potent against parasitic worms such as Brugia, which causes lymphatic filariasis and Trichuris, one of the soil-transmitted helminths that infects millions of people globally. Notably, the identified molecular targets indicate a mechanism of action that differs greatly from that of the parental antifungal drug, including targets involved in biosynthetic pathways that are absent in humans, offering great potential to expand our armamentarium against drug-resistant fungal infections and neglected tropical diseases (NTDs) targeted for elimination by 2030
Lin, Y.; Jung, H.; Bulman, C.A.; Ng, J.; Vinck, R.; O'Beirne, C.; Moser, M.S.; Tricoche, N.; Peguero, R.; Li, R.W.; Urban, J.F.; Le Pape, P.; Pagniez, F.; Moretto, M.; Weil, T.; Lustigman, S.; Cariou, K.; Mitreva, M.; Sakanari, J.; Gasser, G. (2023). Discovery of new broad-spectrum anti-infectives for eukaryotic pathogens using bioorganometallic chemistry. JOURNAL OF MEDICINAL CHEMISTRY, 66 (23): 15867-15882. doi: 10.1021/acs.jmedchem.3c01333 handle: https://hdl.handle.net/10449/83136
Discovery of new broad-spectrum anti-infectives for eukaryotic pathogens using bioorganometallic chemistry
Moretto, Marco;Weil, Tobias
;
2023-01-01
Abstract
Drug resistance observed with many anti-infectives clearly highlights the need for new broad-spectrum agents to treat especially neglected tropical diseases (NTDs)caused by eukaryotic parasitic pathogens, including fungal infections. Herein, we show that the simple modification of one of the most well-known antifungal drugs, fluconazole, with organometallic moieties not only improves the activity of the parent drug but also broadens the scope of application of the new derivatives. These compounds were highly effective in vivo against pathogenic fungal infections and potent against parasitic worms such as Brugia, which causes lymphatic filariasis and Trichuris, one of the soil-transmitted helminths that infects millions of people globally. Notably, the identified molecular targets indicate a mechanism of action that differs greatly from that of the parental antifungal drug, including targets involved in biosynthetic pathways that are absent in humans, offering great potential to expand our armamentarium against drug-resistant fungal infections and neglected tropical diseases (NTDs) targeted for elimination by 2030File | Dimensione | Formato | |
---|---|---|---|
2023 JMC Weil.pdf
solo utenti autorizzati
Tipologia:
Versione editoriale (Publisher’s layout)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
8.41 MB
Formato
Adobe PDF
|
8.41 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.